Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @RBWConsulting
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @RBWConsulting
-
We would like to wish our colleagues, clients, candidates and wider network a very Happy New Year! We wish you every success for 2020!
#HappyNewYearpic.twitter.com/1bKHphjcke
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our offices are now closed for the festive break - we will be back onsite on Thursday 2nd January. If you need to make contact with us, please email info@rbwconsulting.compic.twitter.com/ZwS7vXbwhk
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Kimberley, Nick and Sherry had a great first day at
#OCTNewEngland yesterday - if you are attending day two, pop over to booth 50 to meet our team!#Boston#conference#networkingpic.twitter.com/NmIFmuZeyp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The team are making there way to Boston for the first day of
#OCTNewEngland tomorrow - come and find the team at Booth 50 through the event!Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Safe travels to all making their way to Boston over the weekend for
#OCTNewEngland - we look forward to a great event next week.Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Next week our team will be heading to
#OCTNewEngland in Boston. If you would like to meet RBW to discuss career options or team expansion, feel free to drop by booth 50 throughout the event#clinicaltrials#networkingpic.twitter.com/yQUf2ytXyN
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Who is head to
#OCTNewEngland in October? Meet our team at booth 50 throughout the event#clinicaltrials#conference#networkingpic.twitter.com/mQpC9UBGs8
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The UK team are back in the office following the Bank Holiday weekend. If you feel it is time for a change or if you need support finding talent for your team, get in touch today +44 (0)1293 584 300
#lifescience#IT#jobs#recruitment#pharma#technologypic.twitter.com/8W3vyHrY6Z
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are heading to
#JSM2019 in Denver, Colorado towards the end of July. There is still time to register for the event, see details here: https://ww2.amstat.org/meetings/jsm/2019/ …#statisticspic.twitter.com/2yQtBYAajs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
It is great to see many of the clients we are recruiting for included in this list which spam across many therapeutic fields including oncology and immunology - Top 20 drugs by 2018 U.S. sales https://www.fiercepharma.com/special-report/top-20-drugs-by-2018-u-s-sales …
#pharmaceutical#oncology#healthcareHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bluebird Bio’s gene therapy treatment for beta thalassemia Zynteglo is to be priced at €1.575m ($1.76m) in Europe, where the first patients are expected to be treated later this year.http://www.pmlive.com/pharma_news/bluebird_puts_1.57m_price_on_gene_therapy_zynteglo_1291433 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Biogen has announced that it has completed its acquisition of Sycona’s Nightstar Therapeutics, the clinical-stage gene therapy company, which is focused on adeno-associated virus (AAV) treatments for inherited retinal disorders. Via
@PharmaTimeshttp://www.pharmatimes.com/news/biogen_completes_nightstar_acquisition_1290282 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are attending
#OCTUK tomorrow and Wednesday in London. The team are available for meetings throughout the event if you would like to discuss how you can partner with RBW, DM for more info#WeAreRBW#networking#conference#Londonpic.twitter.com/BTl4Smd8xh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Bluebird bio has announced that its gene therapy Zynteglo has been granted conditional marketing authorisation in Europe for certain patients 12 years and older with transfusion-dependent β-thalassaemia (TDT). http://www.pharmatimes.com/news/bluebird_bags_eu_conditional_marketing_authorisation_for_zynteglo_1289757 …
#clinicaltrials#healthcareHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Allergan puts Vraylar on blockbuster track with new bipolar depression nod https://www.fiercepharma.com/pharma/allergan-puts-vraylar-blockbuster-track-new-depression-nod …
#bipolar#clinicaltrials#healthcareHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The R&D executive shake-up at AstraZeneca continues apace as it hires academic cancer researcher Dr. Sunil Verma to run its breast cancer work. https://www.fiercebiotech.com/biotech/astrazeneca-hires-r-d-exec-to-lead-breast-cancer-research-7b-daiichi-drug-pact …
#healthcare#cancer#clinicaltrialsHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
A new test can genetically ‘barcode’ bowel cancer and separate it into five different diseases that could each receive tailored treatment, a new study reports. https://www.icr.ac.uk/news-archive/new-barcode-test-divides-bowel-cancer-into-five-diseases?utm_content=buffer97b1a&utm_medium=social&utm_source=linkedin.com&utm_campaign=buffer …
#cancer#clinicaltrials#healthcareHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The National Institute for Health Research (NIHR) has announced a clinical trial to improve the diagnosis and treatment of a potentially life-threatening infection in newborn babies. http://www.pharmatimes.com/news/new_screening_to_help_detect_group_b_strep_in_pregnant_women_1288683 …
#clinicaltrial#healthcareHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The National Institute for Health Research (NIHR) has announced that a record number of patients are now taking part in clinical trials. http://www.pharmatimes.com/news/record_number_of_patients_taking_part_in_clinical_trials_1288739 …
#healthcare#clinicaltrials#NHSHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Biogen's Spinraza gets a boost from NICE as competitors loom via
@FiercePharma https://www.fiercepharma.com/pharma/biogen-s-spinraza-wins-nice-recommendation-helping-its-case-sma-as-competitors-loom …#clinicaltrials#healthcareHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.